McKesson Declares Quarterly Dividend of $0.94 Per Share
McKesson Corporation has declared a quarterly dividend of $0.94 per share, payable on January 4, 2027, to shareholders of record as of December 1, 2026.
Stocks · News reference
Study Highlights Impact of Ambient AI on Oncology Practice Efficiency
A research study co-authored by representatives from McKesson/The US Oncology demonstrates that ambient AI technology significantly improves documentation efficiency and reduces provider burnout in community oncology practices.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
McKesson Corporation Declares Quarterly Dividend of $0.94 Per Share
McKesson Corporation has announced a quarterly dividend payment of $0.94 per share.
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Amgen and Bristol Myers Squibb represent different investment approaches in pharmaceuticals. Amgen demonstrates stronger revenue growth (~10% YoY) with higher profitability margins (21%) but trades at a premium valuation (P/E 26.4x). Bristol Myers Squibb offers significantly lower valuation (P/E 12.96x) and higher dividend yield (4.1%) with stronger free cash flow ($12.8B), though facing revenue headwinds and generic competition. For long-term dividend-focused investors, Bristol Myers Squibb is recommended despite near-term challenges.